- Current report filing (8-K)
October 27 2008 - 4:01PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of
the
Securities Exchange Act of 1934
October
27, 2008
Date
of
Report (Date of earliest event reported)
NORTH
AMERICAN SCIENTIFIC, INC.
(Exact
name of Registrant as Specified in Its Charter)
Delaware
|
0-26670
|
51-0366422
|
(State
or other jurisdiction of incorporation)
|
(Commission
File Number)
|
(IRS
Employer Identification No)
|
20200
Sunburst Street, Chatsworth, CA 91311
(Address
of principal executive offices)
(818)
734-8600
(Registrant's
telephone number, including area code)
Not
Applicable
(Former
name or former address, if changed since last report)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR
230.425)
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR
240.14d-2(b))
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR
240.13e-4(c))
|
Item
3.01
Notice
of Delisting or Failure to Satisfy a Continued Listing Rule or Standard;
Transfer of Listing
On
October 24, 2008, North American Scientific, Inc. (the “Company”) received a
letter from The Nasdaq Stock Market (“Nasdaq”) indicating that the Company is in
compliance with the minimum $2.5 million stockholders’ equity requirement for
continued listing. As a result of regaining compliance with Nasdaq Marketplace
Rules, The Nasdaq Listing Qualifications Panel has determined that the hearing
scheduled for October 30, 2008 is no longer necessary. The Company’s common
stock will continue to be listed on The Nasdaq Capital Market and will continue
to trade under the symbol “NASM.”
In
a
related matter, the Company received a letter from Nasdaq dated October 22,
2008
notifying the Company that Nasdaq has suspended enforcement of the bid price
and
market value of publicly held shares requirements through Friday, January 16,
2009. The Company is currently in a bid price compliance period and as a result
of this suspension, the Company will have until May 26, 2009 to regain
compliance by achieving a $1 closing bid price for a minimum of 10 consecutive
trading days.
The
Company issued a press release regarding the notices that it received from
Nasdaq. A copy of the press release is attached hereto as Exhibit 99.1 and
is
incorporated by reference herein.
Item
9.01
Financial
Statements and Exhibits.
|
Exhibit
Number
|
Description
|
|
99.1
|
Press
release, dated October 27, 2008.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
|
|
NORTH
AMERICAN SCIENTIFIC, INC.
|
|
|
|
Date:
October 27, 2008
|
By:
|
/s/ John
B. Rush
|
|
John
B. Rush
|
|
President
and Chief Executive Officer
|
Exhibit Index
Exhibit
Number
|
Description
|
99.1
|
Press
release, dated October 27, 2008
|
North American Scientific (MM) (NASDAQ:NASM)
Historical Stock Chart
From Jun 2024 to Jul 2024
North American Scientific (MM) (NASDAQ:NASM)
Historical Stock Chart
From Jul 2023 to Jul 2024